Awarded

Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.

Descriptions

The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.

Timeline

Published Date :

7th Jul 2022 2 years ago

Deadline :

4th May 2022 2 years ago

Tender Awarded :

1 Supplier

Awarded date :

5th May 2022

Contract Start :

5th May 2022

Contract End :

5th May 2022

Tender Regions

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Awarded

Assign to :

Tender Progress :

0%

Details

Notice Type :

Open opportunity

Tender Identifier :

IT-378-246-T: 2024 - 001

TenderBase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Region :

North Region

Attachments :

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Designation :

Chief Executive Officer

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors